Application of High-Throughput Flow Cytometry in Early Drug Discovery: An AstraZeneca Perspective.
Saved in:
| Title: | Application of High-Throughput Flow Cytometry in Early Drug Discovery: An AstraZeneca Perspective. |
|---|---|
| Authors: | Ding M; 1 Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden., Clark R; 2 Discovery Sciences, IMED Biotech Unit, AstraZeneca, Cambridge, UK., Bardelle C; 3 Discovery Sciences, IMED Biotech Unit, AstraZeneca, Macclesfield, UK., Backmark A; 1 Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden., Norris T; 1 Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden., Williams W; 4 Antibody Discovery and Protein Engineering, MedImmune, Cambridge, UK., Wigglesworth M; 3 Discovery Sciences, IMED Biotech Unit, AstraZeneca, Macclesfield, UK., Howes R; 1 Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden. |
| Source: | SLAS discovery : advancing life sciences R & D [SLAS Discov] 2018 Aug; Vol. 23 (7), pp. 719-731. Date of Electronic Publication: 2018 May 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: SAGE Publications Country of Publication: United States NLM ID: 101697563 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2472-5560 (Electronic) Linking ISSN: 24725552 NLM ISO Abbreviation: SLAS Discov Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
